US Patent Issued to PROMETHEUS BIOSCIENCES, Cedars-Sinai Medical Center on Aug. 19 for "Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel disease" (American, Australian Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,752, issued on Aug. 19, was assigned to PROMETHEUS BIOSCIENCES INC. (San Diego) and Cedars-Sinai Medical Center (Los Angeles).

"Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel disease" was invented by Laurens Kruidenier (San Diego), Mahyar Sabripour (San Diego), Janine Bilsborough (Adelaide, Australia), Dermot P. McGovern (Los Angeles) and Dalin Li (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods, systems, and kits for selecting a patient for treatment with a therapeutic agent based on a presence of a genotype associated with a positive therapeutic response to the th...